Lifesci Capital cut shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from an outperform rating to a market perform rating in a report issued on Monday morning, PriceTargets.com reports. Several other equities analysts have also commented on the company. EF Hutton Acquisition Co. I reaffirmed a buy rating and issued a $16.00 price target on […]
Oppenheimer lowered shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from an outperform rating to a market perform rating in a research report report published on Monday, The Fly reports. A number of other equities research analysts also recently issued reports on the stock. Mizuho decreased their price target on shares of Rain Oncology from […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Analysts at Wedbush raised their FY2025 earnings per share (EPS) estimates for shares of Kura Oncology in a research note issued to investors on Thursday, May 11th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of $2.45 per share for the year, up […]
Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its target price dropped by research analysts at HC Wainwright from $15.00 to $14.00 in a report issued on Tuesday, The Fly reports. Cardiff Oncology Stock Down 3.4 % Shares of Cardiff Oncology stock opened at $1.71 on Tuesday. Cardiff Oncology has a twelve month low of $1.13 […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating)’s share price was down 5.3% during mid-day trading on Tuesday . The company traded as low as $10.88 and last traded at $10.90. Approximately 135,098 shares traded hands during trading, a decline of 79% from the average daily volume of 632,237 shares. The stock had previously closed at […]